Captor Therapeutics

Investor Relations

Reports

RB ESPI 10/2023 / Announcement of the National Securities Depository S.A. on the registration of series M ordinary bearer shares in the securities depository
Publication date: 2023-03-14

RB ESPI 9/2023 / Admission and introduction to exchange trading of series M ordinary bearer shares
Publication date: 2023-03-09

RB ESPI 7/2023 / Captor Therapeutics S.A.'s strategic plans for 2023-2025.
Publication date: 2023-03-06

RB ESPI 6/2023 / Completion of subscription for series M shares issued in connection with the implementation of the Company's employee incentive programme
Publication date: 2023-03-02

RB ESPI 5/2023 / Announcement of the Central Securities Depository of Poland on the conditional registration of series M ordinary bearer shares
Publication date: 2023-03-02

RB ESPI 4/2023 / Information on receipt of NCBR's letter of completion for project CT-04
Publication date: 2023-03-02

RB ESPI 3/2023 / Adoption of a resolution by the Company's Management Board on the issue of shares within the framework of a target share capital increase
Publication date: 2023-02-14

RB ESPI 2/2023 / Registration of share capital increase and amendments to the Company's Articles of Association
Publication date: 2023-02-10

RB ESPI 1/2023 / Dates of publication of periodic reports in 2023
Publication date: 2023-01-17
RB ESPI 14/2022 / Information on transaction in Company shares under Article 19 MAR
Publication date: 2022-05-05

RB ESPI 16/2022 / Information on transaction in Company shares under Article 19 MAR
Publication date: 2022-05-05

RB ESPI 17/2022 / Registration of share capital increase and amendments to the Company's Articles of Association
Publication date: 2022-05-12

RB ESPI 18/2022 / Change of the publication date of the extended consolidated quarterly report for Q1 2022
Publication date: 2022-05-20

RB ESPI 19/2022 / Potential delays to the Company's project
Publication date: 2022-05-27

/ Quartely Report for I quarter 2022
Publication date: 2022-05-30 | 1,688.67 kB

RB ESPI 20/2022 / Notice of convocation of the Ordinary General Shareholders Meeting and draft resolutions of the Ordinary General Shareholders Meeting
Publication date: 2022-06-03

RB ESPI 21/2022 / Submitting Candidates for Members of the Supervisory Board of the Company
Publication date: 2022-06-10

RB ESPI 22/2022 / Completion of subscription of series K shares issued in connection with the implementation of the Company's employee incentive scheme
Publication date: 2022-06-15

RB ESPI 23/2022 / Announcement of the Central Securities Depository of Poland on the conditional registration of series K ordinary bearer shares
Publication date: 2022-06-28

RB EBI 24/2022 / Admission and introduction to exchange trading of series K ordinary bearer shares
Publication date: 2022-06-29

RB ESPI 25/2022 / Announcement of a break in the Ordinary General Meeting of Captor Therapeutics S.A. on 30 June 2022 and the content of the resolutions adopted until the break
Publication date: 2022-06-30

RB ESPI 26/2022 / Announcement of the National Securities Depository S.A. on the registration of series K ordinary bearer shares in the securities depository
Publication date: 2022-06-30

RB ESPI 27/2022 / Appointment of the Company's Supervisory Board, Management Board, Audit Committee and Remuneration Committee for the next term
Publication date: 2022-06-30

RB ESPI 28/2022 / List of shareholders holding at least 5% of votes at the Ordinary General Meeting of the Company on 30 June 2022
Publication date: 2022-07-05

RB ESPI 29/2022 / Contents of the resolutions passed by the Annual General Meeting of Captor Therapeutics S.A. after the resumption of the meeting on 14 July 2022.
Publication date: 2022-07-14

RB ESPI 30/2022 / List of shareholders holding at least 5% of votes at the Ordinary General Meeting of the Company on 14 July 2022
Publication date: 2022-07-19

RB ESPI 31/2022 / Progress in research and development related to CT-01 project
Publication date: 2022-08-08

RB EBI 32/2022 / Information on transaction in Company shares under Article 19 MAR
Publication date: 2022-08-09

RB ESPI 33/2022 / Information on transaction in Company shares under Article 19 MAR
Publication date: 2022-08-09

RB ESPI 34/2022 / Change of the publication date of the extended consolidated semi-annual report for the first half of 2022
Publication date: 2022-08-30

/ Half-year report for the first half of 2022
Publication date: 2022-09-02

RB EBI 35/2022 / Registration of share capital increase and amendments to the Company's Articles of Association
Publication date: 2022-09-07

RB ESPI 36/2022 / Registration of the amendment to the Company's Articles of Association
Publication date: 2022-09-16

RB ESPI 37/2022 / Adoption of a resolution by the Company's Management Board on the issue of shares within the framework of a target share capital increase
Publication date: 2022-09-28

RB ESPI 38/2022 / Information on the status of the CT-04 project
Publication date: 2022-10-31

RB ESPI 39/2022 / Completion of subscription of series L shares issued in connection with the implementation of the Company's employee incentive scheme
Publication date: 2022-11-07

RB ESPI 40/2022 / Conclusion of a collaboration agreement with Ono Pharmaceutical Co., Ltd. and disclosure of delayed confidential information
Publication date: 2022-11-14

RB ESPI 41/2022 / Final settlement of audit results with NCBiR
Publication date: 2022-11-16

/ Quartely Report for III quarter 2022
Publication date: 2022-11-24 | 1,750.48 kB

RB ESPI 42/2022 / Announcement of the Central Securities Depository of Poland on the conditional registration of series L ordinary bearer shares
Publication date: 2022-11-22

RB ESPI 43/2022 / Admission and introduction to exchange trading of series L ordinary bearer shares
Publication date: 2022-11-23

RB ESPI 44/2022 / Information on transaction in Company shares under Article 19 MAR
Publication date: 2022-12-02

RB ESPI 45/2022 / Information on expiration of pledge in Company shares under Article 19 MAR
Publication date: 2022-12-08

RB ESPI 47/2022 / Information on transaction in Company shares under Article 19 MAR
Publication date: 2022-12-28

RB ESPI 48/2022 / Information on transaction in Company shares under Article 19 MAR
Publication date: 2022-12-28

RB ESPI 49/2022 / Information on transaction in Company shares under Article 19 MAR
Publication date: 2022-12-29

ZIP / Annual Report 2021
Publication date: 2022-04-29 | 3,611.76 kB

RB ESPI 13/2022 / Adoption of a resolution by the Company's Management Board concerning the issuance of shares as part of an authorized share capital increase
Publication date: 2022-04-27

RB ESPI 12/2022 / Progress in research and development related to CT-01 project
Publication date: 2022-04-19

RB ESPI 11/2022 / Disclosure of molecular targets in CT-01 project
Publication date: 2022-04-11

RB ESPI 10/2022 / Information on receipt by the Company of the results of the Audit
Publication date: 2022-04-08

/ Quarterly Report for III quarter 2021
Publication date: 2021-11-29 | 1,699.31 kB

RB ESPI 9/2022 / Progress in research and development related to CT-03 project
Publication date: 2022-02-24

RB ESPI 8/2022 / List of shareholders holding at least 5% of votes at the Extraordinary General Meeting of the Company on 21 February 2022
Publication date: 2022-02-21

RB ESPI 15/2022 / Information on transaction in Company shares under Article 19 MAR
Publication date: 2022-05-05

RB ESPI 7/2022 / Text of resolutions adopted by the Extraordinary General Meeting on 21 February 2021
Publication date: 2022-02-21

RB ESPI 6/2022 / Dates of publication of periodic reports in 2022
Publication date: 2022-01-26

RB ESPI 5/2022 / Filing by the Company of notification to NCBiR regarding potential irregularities in settlement of eligible costs in EU projects
Publication date: 2022-01-26

RB ESPI 4/2022 / Announcement of convening Extraordinary General Meeting together with draft resolutions
Publication date: 2022-01-25

RB ESPI 3/2022 / Progress in research and development related to CT-01 project
Publication date: 2022-01-11

RB ESPI 2/2022 / Appointment of a member of the Company's Supervisory Board
Publication date: 2022-01-05

RB ESPI 1/2022 / Information on transaction in Company shares under Article 19 MAR
Publication date: 2022-01-05
RB ESPI 29/2021 / Registration of amendments to the Company's Articles of Association
Publication date: 2021-10-14

RB ESPI 30/2021 / Notification of increase in shareholding
Publication date: 2021-10-15

RB ESPI 31/2021 / Notification of increase in shareholding
Publication date: 2021-10-26

/ Half-year report for the first half of 2021
Publication date: 2021-11-29

RB ESPI 28/2021 / The Company purchased specialized laboratory equipment
Publication date: 2021-09-29

RB ESPI 27/2021 / Progress in research and development related to CT-3 project and disclosure of molecular target in CT-3 project
Publication date: 2021-09-28

RB ESPI 26/2021 / Conclusion of a service agreement concerning, among others, investor relations
Publication date: 2021-08-30

RB ESPI 25/2021 / Zakończenie subskrypcji akcji serii G oraz sprzedaży części akcji serii B w ofercie publicznej – uzupełnienie raportu bieżącego nr 4/2021 z 15 kwietnia 2021 r.
Publication date: 2021-07-30

RB EBI 2/2021 / A statement on the company's compliance with the corporate governance principles contained in Best Practice for GPW Listed Companies 2021
Publication date: 2021-07-30 | 103.07 kB

RB ESPI 24/2021 / Appointment of an audit firm (extension of an audit agreement)
Publication date: 2021-07-22

RB ESPI 23/2021 / Information on a transaction in shares of the Company obtained pursuant to Article 19 of MAR
Publication date: 2021-07-02

RB ESPI 22/2021 / Notice of reduction of shareholding interest in Company
Publication date: 2021-07-02

RB ESPI 21/2021 / List of shareholders holding at least 5% of votes at the Ordinary General Meeting of the Company on 29 June 2021
Publication date: 2021-06-30

RB ESPI 20/2021 / Text of resolutions adopted by the Ordinary General Meeting on 29 June 2021
Publication date: 2021-06-29

RB ESPI 19/2021 / Appointment of a member of the Company's Management Board and the Chief Financial Officer
Publication date: 2021-06-29

RB ESPI 18/2021 / Resignation of a member of the Company's Management Board
Publication date: 2021-06-21

RB ESPI 17/2021 / Announcement of KDPW on registration of G series shares in securities depository
Publication date: 2021-06-09

RB ESPI 16/2021 / Designation of the last day of listing of the rights to G series shares and introduction of G series shares to exchange trading
Publication date: 2021-06-09

RB ESPI 15/2021 / A shareholder’s request to include certain matters on the agenda of the Ordinary General Meeting called for 29 June 2021
Publication date: 2021-06-08

RB ESPI 14/2021 / Notice of convocation of the Ordinary General Shareholders Meeting and draft resolutions of the Ordinary General Shareholders Meeting
Publication date: 2021-06-02

RB ESPI 33/2021 / Resignation of a member of the Company's Supervisory Board
Publication date: 2021-12-14

RB ESPI 13/2021 / Notice of reduction of shareholding interest in Company
Publication date: 2021-05-28

RB ESPI 32/2021 / Adoption of a resolution by the Company's Management Board concerning the issuance of shares as part of an authorized share capital increase
Publication date: 2021-12-13

RB ESPI 12/2021 / Notice of reduction of shareholding interest in Company
Publication date: 2021-05-28

RB ESPI 11/2021 / Notice of reduction of shareholding interest in Company
Publication date: 2021-05-28

RB ESPI 10/2021 / Notice of reduction of shareholding interest in Company
Publication date: 2021-05-28

RB ESPI 9/2021 / Notice of reduction of shareholding interest in the Company
Publication date: 2021-05-28

RB ESPI 8/2021 / Registration of the increase of the share capital through the issuance of G series shares
Publication date: 2021-05-24

/ Sprawozdanie finansowe i raport roczny za okres zakończony 31 grudnia 2020
Publication date: 2021-04-30

RB ESPI 7/2021 / Dates of publication of interim reports
Publication date: 2021-04-27

RB ESPI 6/2021 / Introduction of shares and rights to shares to trading on a regulated market
Publication date: 2021-04-16

RB EBI 1/2021 / Detailed rules of corporate governance permanently not applied by the Company
Publication date: 2021-04-15 | 187.02 kB

RB ESPI 5/2020 / KDPW announcements on registration of shares and rights to shares in the securities depository
Publication date: 2021-04-15

RB ESPI 4/2021 / Closing of the subscription of G series shares and sale of a part of B series shares in a public offering
Publication date: 2021-04-15

RB ESPI 3/2021 / Admission of shares and rights to shares to trading
Publication date: 2021-04-15

RB ESPI 2/2021 / Registration of outstanding shares and rights to shares in KDPW
Publication date: 2021-04-15

RB ESPI 1/2021 / Granting of access to the Electronic Reporting System (“ERS”)
Publication date: 2021-04-15

- / Selected financial data for the period of 5 years
Publication date: 2021-12-14 | 14.72 kB